- Home
- ELWS vs CNSP Comparison
ELWS vs CNSP Comparison
Compare ELWS & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- CNSP
- Stock Information
- Founded
- ELWS 2018
- CNSP 2017
- Country
- ELWS Japan
- CNSP United States
- Employees
- ELWS N/A
- CNSP N/A
- Industry
- ELWS
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- CNSP Health Care
- Exchange
- ELWS Nasdaq
- CNSP Nasdaq
- Market Cap
- ELWS 6.1M
- CNSP 5.6M
- IPO Year
- ELWS 2023
- CNSP 2019
- Fundamental
- Price
- ELWS $1.80
- CNSP $0.84
- Analyst Decision
- ELWS
- CNSP Hold
- Analyst Count
- ELWS 0
- CNSP 1
- Target Price
- ELWS N/A
- CNSP N/A
- AVG Volume (30 Days)
- ELWS 74.1K
- CNSP 224.3K
- Earning Date
- ELWS 07-07-2025
- CNSP 08-13-2025
- Dividend Yield
- ELWS N/A
- CNSP N/A
- EPS Growth
- ELWS N/A
- CNSP N/A
- EPS
- ELWS N/A
- CNSP N/A
- Revenue
- ELWS $2,292,406.00
- CNSP N/A
- Revenue This Year
- ELWS N/A
- CNSP N/A
- Revenue Next Year
- ELWS N/A
- CNSP N/A
- P/E Ratio
- ELWS N/A
- CNSP N/A
- Revenue Growth
- ELWS 404.13
- CNSP N/A
- 52 Week Low
- ELWS $1.04
- CNSP $0.73
- 52 Week High
- ELWS $8.68
- CNSP $148.00
- Technical
- Relative Strength Index (RSI)
- ELWS 51.90
- CNSP 38.65
- Support Level
- ELWS $1.85
- CNSP $0.73
- Resistance Level
- ELWS $2.16
- CNSP $0.84
- Average True Range (ATR)
- ELWS 0.09
- CNSP 0.07
- MACD
- ELWS -0.00
- CNSP 0.00
- Stochastic Oscillator
- ELWS 48.39
- CNSP 31.47
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.